01 1APLENZIN
02 1ASACOL HD
03 1ASPRUZYO SPRINKLE
04 1BUPROPION HYDROCHLORIDE
05 1CEFUROXIME AXETIL
06 1COLESTIPOL HYDROCHLORIDE
07 1DELZICOL
08 1DEXEDRINE SPANSULE
09 4DEXTROAMPHETAMINE SULFATE
10 1DILT-CD
11 1DILTIAZEM HYDROCHLORIDE
12 2DIVALPROEX SODIUM
13 1DULOXETINE HYDROCHLORIDE
14 1EMBEDA
15 1FENOFIBRIC ACID
16 2GALANTAMINE HYDROBROMIDE
17 1LAMISIL
18 2LEVETIRACETAM
19 1LUVOX CR
20 1METADATE CD
21 2METFORMIN HYDROCHLORIDE
22 2METHYLPHENIDATE HYDROCHLORIDE
23 4OMEPRAZOLE
24 1PALIPERIDONE
25 1PASER
26 1POTASSIUM CHLORIDE
27 1PROPRANOLOL HYDROCHLORIDE
28 1RIOMET ER
29 1ROXYBOND
30 1TAMSULOSIN HYDROCHLORIDE
31 6TRAMADOL HYDROCHLORIDE
32 1TROXYCA ER
33 1ULTRAM ER
34 1URSO 250
35 1URSO FORTE
36 2VENLAFAXINE HYDROCHLORIDE
37 1VERAPAMIL HYDROCHLORIDE
Drug : ASACOL HD
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 21830
Country : US
Patented : No
Drug : DELZICOL
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 204412
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 76137
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 203481
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 205673
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 75876
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78783
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 205077
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
